Detalles de la búsqueda
1.
Body-Weight Fluctuations and Outcomes in Coronary Disease.
N Engl J Med
; 376(14): 1332-1340, 2017 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28379800
2.
Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
Diabetologia
; 58(7): 1494-502, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25899452
3.
High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect.
Circulation
; 127(25): 2485-93, 2013 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-23674398
4.
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
Circulation
; 128(14): 1504-12, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23965489
5.
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study.
Circulation
; 125(16): 1979-87, 2012 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22461416
6.
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.
Arthritis Rheum
; 64(9): 2836-46, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22576673
7.
Relationship between atorvastatin dose and the harm caused by torcetrapib.
J Lipid Res
; 53(11): 2436-42, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22941786
8.
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
J Lipid Res
; 53(5): 1000-1011, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22368281
9.
Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease.
Am Heart J
; 164(3): 387-93, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22980306
10.
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis.
JAMA
; 308(8): 804-11, 2012 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22910758
11.
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
JAMA
; 307(12): 1302-9, 2012 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22453571
12.
On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study.
Eur J Clin Invest
; 41(2): 134-42, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20868450
13.
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
JAMA
; 305(24): 2556-64, 2011 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21693744
14.
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Circulation
; 117(23): 3002-9, 2008 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18519851
15.
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Clin Chem
; 55(3): 473-80, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19147732
16.
Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
Am J Kidney Dis
; 54(5): 810-9, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19540640
17.
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
J Am Heart Assoc
; 8(9): e010827, 2019 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31020900
18.
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).
Metabolism
; 93: 93-99, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30452928
19.
The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
Diab Vasc Dis Res
; 5(3): 177-83, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18777490
20.
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.
Circ Cardiovasc Qual Outcomes
; 11(11): e004724, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30571333